Activation of the RAS/ERK pathway can induce the occurrence of EMT in bladder cancer through various mechanisms, affecting the expression and function of N-cadherin, vimentin, and E-cadherin [66]. This evidence concerns the gene CDH1 and urinary bladder carcinoma.